Mirum Pharmaceuticals

ISIN US6047491013

WKN A2PM29

Market cap (in EUR)

4,702 m

Country

United States

Sector

Healthcare

Dividend yield

0.00%

Overview

Description

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Show more Show less

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR	4,702 m
EPS, EUR	-0.42
P/B ratio	14.8
P/E ratio	-
Dividend yield	0.00%

Income statement (2025)

Revenue, EUR	462 m
Net income, EUR	-21 m
Profit margin	-4.48%

What ETF is Mirum Pharmaceuticals in?

There are 24 ETFs which contain Mirum Pharmaceuticals. All of these ETFs are listed in the table below. The ETF with the largest weighting of Mirum Pharmaceuticals is the L&G Pharma Breakthrough UCITS ETF.

ETF	Weight	Investment focus	Fund size (in m EUR)
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc)	0.06%	Equity United States Small Cap	60
Amundi MSCI World Small Cap ESG Broad Transition UCITS ETF Acc	0.03%	Equity World Small Cap Climate Change	347
UBS MSCI USA Select Factor Mix UCITS ETF hEUR acc	0.02%	Equity United States Multi-Factor Strategy	8
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF EUR Acc	0.05%	Equity United States Small Cap	66
UBS MSCI USA Select Factor Mix UCITS ETF USD acc	0.02%	Equity United States Multi-Factor Strategy	98
State Street SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Acc)	0.05%	Equity World Small Cap	1,445
Xtrackers Portfolio UCITS ETF 1C	0.00%	Equity World Multi-Asset Strategy	682
L&G Russell 2000 US Small Cap Quality UCITS ETF	0.18%	Equity United States Small Cap	172
Xtrackers Russell 2000 UCITS ETF 1C	0.14%	Equity United States Small Cap	2,109
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist)	0.06%	Equity United States Small Cap	187
UBS MSCI USA Select Factor Mix UCITS ETF USD dis	0.02%	Equity United States Multi-Factor Strategy	24
UBS MSCI USA Select Factor Mix UCITS ETF hCHF acc	0.02%	Equity United States Multi-Factor Strategy	24
iShares MSCI USA Small Cap ESG Enhanced CTB UCITS ETF USD (Acc)	0.02%	Equity United States Small Cap	2,425
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing	0.01%	Equity World Multi-Factor Strategy	168
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0.40%	Equity United States Health Care Biotech	47
iShares MSCI World Small Cap UCITS ETF	0.04%	Equity World Small Cap	6,549
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating	0.01%	Equity World Multi-Factor Strategy	970
iShares Nasdaq US Biotechnology UCITS ETF	0.40%	Equity United States Health Care Biotech	768
State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF USD	0.01%	Equity United States Small Cap	758
State Street SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Dist)	0.04%	Equity World Small Cap	31
iShares MSCI World Small Cap ESG Enhanced CTB UCITS ETF USD (Acc)	0.01%	Equity World Small Cap	419
State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF USD	0.10%	Equity United States Small Cap	4,234
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF USD Acc	0.05%	Equity United States Small Cap	26
L&G Pharma Breakthrough UCITS ETF	3.40%	Equity World Health Care Innovation	17

Change your settings